AR130185A1 - Cápsulas blandas de disolución rápida - Google Patents

Cápsulas blandas de disolución rápida

Info

Publication number
AR130185A1
AR130185A1 ARP230102126A ARP230102126A AR130185A1 AR 130185 A1 AR130185 A1 AR 130185A1 AR P230102126 A ARP230102126 A AR P230102126A AR P230102126 A ARP230102126 A AR P230102126A AR 130185 A1 AR130185 A1 AR 130185A1
Authority
AR
Argentina
Prior art keywords
soft capsule
film
capsule film
bio
gelatin
Prior art date
Application number
ARP230102126A
Other languages
English (en)
Spanish (es)
Inventor
Soo Ah Jin
Qi Fang
Karunakar Sukuru
Aris Gennadios
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR130185A1 publication Critical patent/AR130185A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP230102126A 2022-08-12 2023-08-11 Cápsulas blandas de disolución rápida AR130185A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263397554P 2022-08-12 2022-08-12

Publications (1)

Publication Number Publication Date
AR130185A1 true AR130185A1 (es) 2024-11-13

Family

ID=89852410

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230102126A AR130185A1 (es) 2022-08-12 2023-08-11 Cápsulas blandas de disolución rápida

Country Status (13)

Country Link
US (1) US20250057774A1 (https=)
EP (1) EP4568657A1 (https=)
JP (1) JP2025527331A (https=)
KR (1) KR20250047815A (https=)
CN (1) CN119907662A (https=)
AR (1) AR130185A1 (https=)
AU (1) AU2023321676A1 (https=)
CA (1) CA3263875A1 (https=)
CO (1) CO2025002953A2 (https=)
MX (1) MX2025001366A (https=)
TW (1) TW202408464A (https=)
UY (1) UY40394A (https=)
WO (1) WO2024035911A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100047349A (ko) * 2001-11-22 2010-05-07 모리시타 진탄 가부시키가이샤 비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
BR112013002721B8 (pt) * 2010-08-04 2021-05-25 Scherer Technologies Llc R P composição formadora de filme para cápsulas moles, cápsulas moles e seu invólucro
WO2012126140A1 (zh) * 2011-03-21 2012-09-27 博任达生化科技(上海)有限公司 逆向温敏可逆水凝胶组合物
MX2015011163A (es) * 2013-03-15 2016-02-17 Banner Life Sciences Llc Capsula entericas blandas que no contienen gelatina.
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
KR20220080130A (ko) * 2019-10-09 2022-06-14 알.피.쉐러 테크놀러지즈 엘엘씨 비-동물 소프트겔 캡슐 제제, 그의 제조 방법 및 사용 방법
CN113332257B (zh) * 2021-06-28 2023-05-05 仙乐健康科技股份有限公司 软胶囊囊壳和软胶囊
WO2023283226A1 (en) * 2021-07-06 2023-01-12 R.P. Scherer Technologies, Llc Softgel capsule

Also Published As

Publication number Publication date
US20250057774A1 (en) 2025-02-20
CA3263875A1 (en) 2024-02-15
CN119907662A (zh) 2025-04-29
CO2025002953A2 (es) 2025-03-27
TW202408464A (zh) 2024-03-01
KR20250047815A (ko) 2025-04-04
WO2024035911A9 (en) 2024-12-26
AU2023321676A1 (en) 2025-03-20
WO2024035911A1 (en) 2024-02-15
MX2025001366A (es) 2025-03-07
UY40394A (es) 2024-02-15
EP4568657A1 (en) 2025-06-18
JP2025527331A (ja) 2025-08-20

Similar Documents

Publication Publication Date Title
PE20061160A1 (es) Sistema de administracion de farmacos con retencion gastrica
US20110142942A1 (en) USE OF pH SENSITIVE COMPOUNDS IN TASTE MASKING OF DRUG SUBSTANCES WITHIN ORAL THIN FILM STRIPS
CN102824333B (zh) 一种口腔速溶膜剂及其制备方法
ES2035263T3 (es) Composicion de pelicula de polimero para la liberacion durante el aclarado de aditivos de lavado.
CO2022005947A2 (es) Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas
CY1118258T1 (el) Εντεροδιαλυτη συνθεση για την παρασκευη περιβληματος μαλακης καψουλας
PL187764B1 (pl) Tabletki farmaceutyczne o kontrolowanym uwalnianiu zawierające nośnik oparty na sieciowanej amylozie i hydroksypropylometylocelulozie oraz zastosowanie hydroksypropylometylocelulozy
PT1809261E (pt) Sistema de cápsula mole não gelatinosa
PE20040675A1 (es) Formulaciones de deposito de liberacion controlada
AR029494A1 (es) Peliculas consumibles oralmente que se disuelven rapidamente que contienen una resina de intercambio de iones como agente que enmascara el sabor
JP4768945B2 (ja) 膨潤及び解膨潤するポリマーブレンド
HUP0402451A2 (hu) Készítmény és dózisforma hidrofil makromolekulák orális biohasznosíthatóságának fokozására
AR069281A2 (es) Composicion farmaceutica de liberacion sostenida y uso de la misma para preparar medicamentos
El-Said et al. Baclofen novel gastroretentive extended release gellan gum superporous hydrogel hybrid system: in vitro and in vivo evaluation
AR130185A1 (es) Cápsulas blandas de disolución rápida
BRPI0709549A2 (pt) métodos para estabilizar composições instáveis oxidativamente
Tang et al. Swelling behavior and biocompatibility of Carbopol‐containing superporous hydrogel composites
JP2025148337A5 (https=)
ES2173739T3 (es) Forma farmaceutica multiparticular con liberacion programada y pulsada y su procedimiento de preparacion.
Arianto et al. The comparison of swelling, mucoadhesive, and release of ranitidine from spherical matrices of alginate, chitosan, alginate-chitosan, and calcium alginate-chitosan
DE60017444D1 (de) Pharmazeutische formulierungen auf basis fester dispersionen
CN101087595A (zh) 用于缓释药物的片剂
WO2021260145A1 (fr) Procede d'incorporation de composes organiques en solution au sein d'un hydrogel
Nguyen et al. Evaluation of Ibuprofen Prolonged Release of Biomedical PLA‐PEG‐PLA Hydrogel via Degradation Mechanism
BR112022024391A2 (pt) Cápsulas de gelatina mole para liberação retardada